+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Middle East AI in Oncology Market Size, Share & Trends Analysis Report by Component (Software Solutions, Hardware), by Cancer Type (Breast Cancer, Lung Cancer), by Application, by End-use, by Country, and Segment Forecasts, 2025-2033- Product Image
Middle East AI in Oncology Market Size, Share & Trends Analysis Report by Component (Software Solutions, Hardware), by Cancer Type (Breast Cancer, Lung Cancer), by Application, by End-use, by Country, and Segment Forecasts, 2025-2033- Product Image
New

Middle East AI in Oncology Market Size, Share & Trends Analysis Report by Component (Software Solutions, Hardware), by Cancer Type (Breast Cancer, Lung Cancer), by Application, by End-use, by Country, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 100 Pages
  • August 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6168215
Description Jump to:
The Middle East AI in oncology market size was estimated at USD 111.33 million in 2024 and is projected to grow at a CAGR of 21.94% from 2025 to 2033. The rising prevalence of cancer, growing government initiatives, and technological advancements are significant factors contributing to market growth. Increasing cancer prevalence and growing awareness are boosting the demand for integrating AI-powered algorithms in their solutions. The incidence of cancer is rapidly increasing owing to various factors such as a sedentary lifestyle, poor eating habits, and physical inactivity. Rapid advancements in digital technology, owing to partnerships between government, industry players, and other investors in the healthcare ecosystem, are boosting the growth of the AI in oncology industry in Middle East.

For instance, according to an American Society of Clinical Oncology article published in January 2024, around 27,885 new cancer cases were reported in Saudi Arabia in 2020, and this figure is projected to surge to 60,429 by 2040, marking a significant increase of 116.7%. This sharp rise emphasizes the growing cancer burden in the country, driven by factors such as population growth and aging.

Middle East AI In Oncology Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the Middle East AI in oncology market report based on component, cancer type, application, end-use, and region:

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software Solutions
  • Hardware
  • Services

Cancer Type Outlook (Revenue, USD Million, 2021-2033)

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Other

Application Outlook (Revenue, USD Million, 2021-2033)

  • Diagnostics (Pathology, Cancer Radiology)
  • Radiation therapy (Radiotherapy)
  • Research & Development (Drug design, development process, etc.)
  • Chemotherapy
  • Immunotherapy

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Surgical Centers & Medical Institutes
  • Others (Pharmaceutical companies, Research institutes & training centers)

Country Outlook (Revenue, USD Million, 2021-2033)

  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component
1.2.2. Cancer Type Segment
1.2.3. Application Segment
1.2.4. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East AI in Oncology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Middle East AI in Oncology Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
3.4. Health-tech Innovation Analysis
3.5. Case Studies
Chapter 4. Middle East AI in Oncology Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East AI in Oncology Market Component Movement Analysis
4.3. Middle East AI in Oncology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Hardware
4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.5. Software Solutions
4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Middle East AI in Oncology Market: Cancer Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East AI in Oncology Market Cancer Type Movement Analysis
5.3. Middle East AI in Oncology Market Size & Trend Analysis, by Cancer Type, 2021 to 2033 (USD Million)
5.4. Breast Cancer
5.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.5. Lung Cancer
5.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.6. Prostate Cancer
5.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.7. Colorectal Cancer
5.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.8. Brain Tumor
5.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Middle East AI in Oncology Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East AI in Oncology Market Application Movement Analysis
6.3. Middle East AI in Oncology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Diagnostics
6.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.5. Radiation therapy
6.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.6. Research & Development
6.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.7. Chemotherapy
6.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.8. Immunotherapy
6.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Middle East AI in Oncology Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East AI in Oncology Market End Use Movement Analysis
7.3. Middle East AI in Oncology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals
7.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.5. Surgical Centers & Medical Institutes
7.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.6. Others
7.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Middle East AI in Oncology Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
8.3. Middle East
8.3.1. Saudi Arabia
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework
8.3.1.3. Competitive scenario
8.3.1.4. Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
8.3.2. UAE
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework
8.3.2.3. Competitive scenario
8.3.2.4. UAE market estimates and forecasts, 2021-2033 (USD Million)
8.3.3. Kuwait
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework
8.3.3.3. Competitive scenario
8.3.3.4. Kuwait market estimates and forecasts, 2021-2033 (USD Million)
8.3.4. Qatar
8.3.4.1. Key country dynamics
8.3.4.2. Regulatory framework
8.3.4.3. Competitive scenario
8.3.4.4. Qatar market estimates and forecasts, 2021-2033 (USD Million)
8.3.5. Oman
8.3.5.1. Key country dynamics
8.3.5.2. Regulatory framework
8.3.5.3. Competitive scenario
8.3.5.4. Oman market estimates and forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Lunit Inc.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Siemens Healthineers AG
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. GE HealthCare
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. NVIDIA Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Roche
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Insilico Medicine
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Oracle
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Intel Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Middle East AI in oncology market, by country, 2021-2033 (USD Million)
Table 3 Middle East AI in oncology market, by component, 2021-2033 (USD Million)
Table 4 Middle East AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 5 Middle East AI in oncology market, by application, 2021-2033 (USD Million)
Table 6 Middle East AI in oncology market, by end use, 2021-2033 (USD Million)
Table 7 Saudi Arabia AI in oncology market, by component, 2021-2033 (USD Million)
Table 8 Saudi Arabia AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 9 Saudi Arabia AI in oncology market, by application, 2021-2033 (USD Million)
Table 10 Saudi Arabia AI in oncology market, by end use, 2021-2033 (USD Million)
Table 11 UAE AI in oncology market, by component, 2021-2033 (USD Million)
Table 12 UAE AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 13 UAE AI in oncology market, by application, 2021-2033 (USD Million)
Table 14 UAE AI in oncology market, by end use, 2021-2033 (USD Million)
Table 15 Kuwait AI in oncology market, by component, 2021-2033 (USD Million)
Table 16 Kuwait AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 17 Kuwait AI in oncology market, by application, 2021-2033 (USD Million)
Table 18 Kuwait AI in oncology market, by end use, 2021-2033 (USD Million)
Table 19 Qatar AI in oncology market, by component, 2021-2033 (USD Million)
Table 20 Qatar AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 21 Qatar AI in oncology market, by application, 2021-2033 (USD Million)
Table 22 Qatar AI in oncology market, by end use, 2021-2033 (USD Million)
Table 23 Oman AI in oncology market, by component, 2021-2033 (USD Million)
Table 24 Oman AI in oncology market, by cancer type, 2021-2033 (USD Million)
Table 25 Oman AI in oncology market, by application, 2021-2033 (USD Million)
Table 26 Oman AI in oncology market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Market formulation & validation
Figure 5 Middle East AI in oncology market: Market outlook
Figure 6 Middle East AI in oncology market: Segment outlook
Figure 7 Middle East AI in oncology market: Competitive landscape outlook
Figure 8 Parent market outlook
Figure 9 Middle East AI in oncology market driver impact
Figure 10 Middle East AI in oncology market restraint impact
Figure 11 Middle East AI in oncology market: Component type outlook and key takeaways
Figure 12 Middle East AI in oncology market: Component type movement analysis
Figure 13 Hardware market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Software solutions market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Middle East AI in oncology market: Cancer Type outlook and key takeaways
Figure 17 Middle East AI in oncology market: Cancer Type movement analysis
Figure 18 Breast cancer market estimates and forecasts,2021-2033 (USD Million)
Figure 19 Lung cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Prostate cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Colorectal cancer market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Brain tumor market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Other cancers market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Middle East AI in oncology market: Application outlook and key takeaways
Figure 25 Middle East AI in oncology market: Application movement analysis
Figure 26 Diagnostics estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Radiation therapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Research & development market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Chemotherapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Immunotherapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Middle East AI in oncology market: End use outlook and key takeaways
Figure 32 Middle East AI in oncology market: End use movement analysis
Figure 33 Hospitals market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Surgical centers & medical institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Middle East AI in oncology market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Saudi Arabia key country dynamics
Figure 38 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 UAE key country dynamics
Figure 40 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Kuwait key country dynamics
Figure 42 Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Qatar key country dynamics
Figure 44 Qatar market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Oman key country dynamics
Figure 46 Oman market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The major companies profiled in this Middle East AI in Oncology market report include:
  • Lunit Inc.
  • Siemens Healthineers AG
  • GE HealthCare
  • NVIDIA Corporation
  • Roche
  • Insilico Medicine
  • Oracle
  • Intel Corporation

Table Information

Report AttributeDetails
No. of Pages100
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 111.33 Million
Forecasted Market Value ( USD ) by 2033 $ 786.46 Million
Compound Annual Growth Rate21.9%
Regions CoveredMiddle East
No. of Companies Mentioned9

Related Topics

Related Reports

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 125 Pages
  • Global
From
Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033 - Product Image

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Oncology Information Systems Market Report by Product and Services, Application, End User, and Region 2025-2033 - Product Image

Oncology Information Systems Market Report by Product and Services, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Oncology Based in-Vivo CRO Market Report by Indication, Model, Application, and Region 2025-2033 - Product Image

Oncology Based in-Vivo CRO Market Report by Indication, Model, Application, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Artificial Intelligence (AI) in Oncology Market Report 2023-2033 - Product Image

Artificial Intelligence (AI) in Oncology Market Report 2023-2033

  • Report
  • 289 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.